⌘K

Home/Filings/4/0001250853-14-000043

4//SEC Filing

Galena Biopharma, Inc. 4

Accession 0001250853-14-000043

$SLSCIK 0001390478operating

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 7:41 PM ET

Size

23.8 KB

Accession

0001250853-14-000043

Insider Transaction Report

Form 4

Period: 2014-02-03

Galena Biopharma, Inc.GALE

GALLIKER STEPHEN S

Director

Transactions

Exercise/Conversion
Common Stock
2014-02-03$1.71/sh+50,000$85,500→ 310,000 total
Exercise/Conversion
Stock Option (right to buy)
2014-02-03−50,000→ 0 total
Exercise: $2.31Exp: 2021-01-13→ Common Stock (50,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2014-02-03−50,000→ 0 total
Exercise: $0.85From: 2011-09-27Exp: 2021-09-27→ Common Stock (50,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2014-02-03−50,000→ 0 total
Exercise: $0.72Exp: 2022-01-12→ Common Stock (50,000 underlying)
Exercise/Conversion
Common Stock
2014-02-03$2.31/sh+50,000$115,500→ 60,000 total
Exercise/Conversion
Common Stock
2014-02-03$0.85/sh+50,000$42,500→ 210,000 total
Exercise/Conversion
Common Stock
2014-02-03$0.72/sh+50,000$36,000→ 260,000 total
Sale
Common Stock
2014-02-03$4.18/sh−300,000$1,253,040→ 10,000 total
Exercise/Conversion
Stock Option (right to buy)
2014-02-03−100,000→ 0 total
Exercise: $1.18Exp: 2021-03-24→ Common Stock (100,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2014-02-03−50,000→ 0 total
Exercise: $1.71Exp: 2023-01-29→ Common Stock (50,000 underlying)
Exercise/Conversion
Common Stock
2014-02-03$1.18/sh+100,000$118,000→ 160,000 total

Footnotes (5)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.16 to $4.47 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F2]The option vested in equal quarterly installments of 12,500 on each of March 31, 2011, June 30, 2011, September 30, 2011 and December 31, 2011.
[F3]The option vested in equal quarterly installments of 25,000 on each of June 25, 2011, September 25, 2011, December 25, 2011 and March 25, 2012.
[F4]The option vested in equal quarterly installments of 12,500 on each of April 12, 2012, July 12, 2012, October 12, 2012 and January 12, 2013.
[F5]The option vested in equal quarterly installments of 12,500 on each of April 29, 2013, July 29, 2013, October 29, 2013 and January 29, 2014.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Galena Biopharma, Inc.

CIK 0001390478

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001390478

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 7:41 PM ET
Size: 23.8 KB

View on SEC.gov